Digital Health For Cardiovascular Market (2026 - 2033)

Digital Health For Cardiovascular Market Summary

The global digital health for cardiovascular market size was valued at USD 50.2 billion in 2025 and is projected to grow from USD 59.0 billion in 2026 to USD 158.9 billion by 2033, at a CAGR of 15.2% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 38.1% in 2025. The rising prevalence of cardiovascular diseases and the demand for continuous, technology-enabled care are accelerating the adoption of digital health solutions for cardiovascular management.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

Key Market Trends & Insights

• By component: The software segment held the largest market share of 39.1% in 2025.
• By end-use: The patient segment held a dominant market share of 34.5% in 2025.

Regional Highlights

• Largest regional market: North America (38.1% revenue share, 2025)
• Fastest-growing regional market: Asia Pacific (highest CAGR, 2026-2033)
• By country: The U.S. held the largest market share in 2025.

Market Size & Forecast

• Market size in 2025: USD 50.2 Billion
• Estimated market size in 2026: USD 59.0 Billion
• Projected market size by 2033: USD 158.9 Billion
• CAGR (2026-2033): 15.2%

Technologies such as remote patient monitoring, wearable devices, mobile health applications, telecardiology, and AI-enabled diagnostic platforms enable early disease detection, ongoing monitoring, and personalized treatment.

To learn more about this report, Download Free Sample Report

These tools help healthcare providers improve disease management, increase patient engagement, and ease the strain on traditional healthcare systems.

Market Dynamics

The digital health for cardiovascular market is experiencing significant growth, driven by the increasing adoption of remote patient monitoring, wearable cardiac devices, telecardiology, artificial intelligence (AI), and connected health platforms that enable continuous and personalized cardiovascular care. The rising prevalence of cardiovascular diseases, growing emphasis on early diagnosis and preventive care, and increasing demand for value-based healthcare are accelerating the integration of digital technologies across clinical and home care settings. In addition, advancements in AI-powered analytics, cloud-based platforms, and interoperable digital health ecosystems are improving clinical decision-making, patient engagement, and care coordination. However, concerns related to data privacy, cybersecurity, interoperability, regulatory compliance, and the high implementation costs of advanced digital health solutions continue to restrain market adoption, particularly among smaller healthcare providers. Addressing these challenges through secure, scalable, and interoperable digital health technologies is expected to remain a key focus for industry stakeholders and support long-term market growth.

Technological Trend Analysis

Artificial intelligence (AI) is emerging as a transformative technology in the digital health for cardiovascular market by enhancing diagnostic accuracy, clinical decision-making, and predictive disease management. AI algorithms can rapidly analyze complex datasets generated from electrocardiograms (ECGs), echocardiography, cardiac imaging, and electronic health records to identify cardiovascular abnormalities, stratify patient risk, and support earlier diagnosis. These capabilities improve workflow efficiency, reduce diagnostic variability, and enable more personalized treatment planning.

The market is also witnessing rapid advancements in predictive analytics and machine learning, enabling healthcare providers to anticipate disease progression and optimize clinical interventions. For instance, a UHN-led study published in Nature in March 2026 demonstrated that AI models using smartwatch-derived physiological data could predict worsening heart failure days to weeks before hospitalization by estimating changes in cardiopulmonary fitness. Furthermore, the ongoing developments in AI, cloud computing, and interoperable digital health platforms are improving clinician confidence, facilitating integration into existing healthcare workflows, and accelerating the adoption of AI-enabled cardiovascular solutions across hospitals, outpatient clinics, and home healthcare settings.

Market Concentration & Characteristics

The digital health for cardiovascular market exhibits a high degree of innovation, driven by rapid advancements in artificial intelligence (AI), wearable technologies, remote patient monitoring (RPM), cloud-based analytics, and connected care platforms. Continuous innovation is enhancing real-time patient monitoring, predictive risk assessment, and personalized disease management while expanding cardiovascular care beyond traditional clinical settings. For instance, in  August 2025, Respiree received FDA 510(k) clearance for its RS001 cardio-respiratory wearable and 1Bio connected care platform, expanding passive cardio-respiratory monitoring into home-based care. This development highlights the growing integration of wearable sensors, AI-enabled analytics, and connected digital health platforms to support continuous cardiovascular monitoring and improve clinical decision-making.

Partnership and collaboration activities are high as technology companies, healthcare providers, and medical organizations increasingly combine capabilities to advance digital cardiovascular care. For instance, in November 2025, the American College of Cardiology partnered with OpenEvidence to develop AI-enabled tools that integrate cardiovascular clinical guidance and research into clinical decision-making. Such collaborations are strengthening the integration of artificial intelligence and evidence-based digital tools into cardiovascular care.

To learn more about this report, Download Free Sample Report

The impact of regulations is moderately high in the digital health for cardiovascular market, as companies must comply with requirements related to data privacy, cybersecurity, medical device safety, artificial intelligence, and clinical validation. These regulations influence product development, approval, commercialization, and data management practices. As regulatory requirements become more stringent, vendors are required to invest in compliance systems, cybersecurity infrastructure, and software governance, increasing operational complexity and influencing market growth.

Geographical expansion is high as companies increasingly extend AI-based diagnostics, connected devices, and digital cardiovascular solutions into new regional markets. For instance, in July 2025, AliveCor launched its AI-powered Kardia 12L ECG system in India following its successful introduction in the U.S., after receiving approval from India’s Central Drugs Standard Control Organization (CDSCO). This expansion is helping extend advanced digital cardiac monitoring technologies into the Asia-Pacific market and broaden access to AI-enabled cardiovascular care.

Case Study: Kafri Heart and Vascular Clinic Elevates Cardiology Care with PrognoCIS EHR

Overview

Kafri Heart & Vascular Clinic, a California-based cardiovascular practice, provides comprehensive cardiac care supported by advanced diagnostic services. To improve clinical documentation, streamline workflows, and transition from paper-based records to a digital environment, the clinic implemented the PrognoCIS cloud-based cardiology electronic health record (EHR) platform. The solution was selected for its specialty-specific functionality, cloud accessibility, and integration with cardiovascular diagnostic workflows.

Challenge

Prior to adopting PrognoCIS, the clinic relied on paper-based documentation, making patient record management and clinical documentation less efficient. Physicians also required secure remote access to patient records and cardiovascular diagnostic information to support timely clinical decision-making across multiple care settings. These limitations affected workflow efficiency and increased the administrative burden associated with managing patient information.

Solution

The clinic implemented PrognoCIS, a cloud-based EHR designed specifically for cardiology practices. The platform offers specialty-specific templates, customizable clinical workflows, secure cloud-based access, and integration with cardiovascular diagnostic equipment. Key capabilities included:

• Cloud-Based Electronic Health Records: Secure access to patient records from any authorized location.

• Specialty-Specific Cardiology Templates: Customized documentation templates for cardiovascular examinations and procedures.

• Diagnostic Integration: Integration with cardiovascular diagnostic systems to improve access to clinical data.

• Customizable Workflow Management: Configurable workflows designed to support efficient clinical documentation and practice operations.

These capabilities enabled the clinic to transition to a fully digital workflow while improving documentation efficiency and accessibility of patient information.

Results

Following implementation, Kafri Heart & Vascular Clinic reported several operational improvements, including:

• Successful transition from paper-based documentation to a cloud-based electronic health record system.

• Improved efficiency in clinical documentation through specialty-specific templates and streamlined workflows.

• Secure remote access to patient records and cardiovascular diagnostic information, enabling physicians to review patient data from multiple locations.

• Enhanced workflow efficiency through integrated documentation and digital record management.

Business Impact

By implementing PrognoCIS, Kafri Heart & Vascular Clinic strengthened its digital infrastructure and improved clinical workflow efficiency. The adoption of a specialty-focused cardiology EHR enhanced documentation, facilitated secure access to patient information, and supported more efficient cardiovascular care delivery. This case illustrates the growing role of cloud-based, specialty-specific digital health platforms in improving operational efficiency and supporting the digital transformation of cardiovascular practices.

Analyst Perspective

The rising burden of cardiovascular diseases is accelerating demand for remote patient monitoring, wearable devices, telehealth platforms, AI-enabled diagnostics, and digital care management solutions. In addition, growing adoption of cloud computing, artificial intelligence, and data analytics is improving real-time cardiovascular monitoring, clinical decision-making, and personalized care. Strengthening requirements for early disease detection, remote access to care, interoperability, and healthcare cost optimization are further supporting market uptake. These factors are expected to support the steady growth of the digital health for cardiovascular market over the forecast period.

Component Insights

The software segment held the largest market share of 39.1% in 2025. The segment's dominance is attributed to the growing adoption of AI-powered cardiovascular analytics, remote patient monitoring platforms, clinical decision support tools, and digital applications for cardiovascular disease management. These solutions enable healthcare providers to analyze data from ECG devices, wearable sensors, and connected monitoring systems, supporting early diagnosis and personalized care. For instance, in July 2025,  the U.S. FDA cleared Anumana's ECG-AI Low Ejection Fraction 12-Lead algorithm, a machine-learning-based software designed to identify patients with reduced ejection fraction from ECG data. Such regulatory clearances support the integration of AI-based software into cardiovascular diagnostic workflows and strengthen demand for software-driven digital health solutions.

The service segment is expected to grow at the fastest growth rate over the forecast period. Growth is driven by the increasing demand for remote patient monitoring, telecardiology, clinical data interpretation, and technology implementation services. The rising adoption of connected cardiovascular devices is also increasing demand for services that support data analysis and clinical decision-making. For instance, in January 2025, Withings introduced its Cardio Check-Up telemedicine service, which provides users with professional reviews of ECG data and cardiologist reports. The growing integration of digital technologies with specialist-led cardiovascular care is expected to support the expansion of the services segment.

End-use Insights

The patients segment held the largest market share of 34.5% in 2025 and is projected to grow at the fastest CAGR over the forecast period. Growth is primarily driven by the increasing adoption of wearable devices, remote patient monitoring (RPM), mobile health applications, and other digital tools that enable individuals to continuously monitor cardiovascular health, support early disease detection, and improve self-management of chronic conditions. For instance, in December 2025, Apple introduced hypertension notifications on Apple Watch in India, using machine learning to analyze heart sensor data over 30-day periods and identify patterns linked to possible hypertension. The feature was trained on data from over 100,000 participants and clinically validated in a study with more than 2,000 participants. Such advancements in consumer-centric digital health technologies are expanding access to continuous cardiovascular monitoring, enhancing patient engagement, and accelerating the adoption of digital health solutions for cardiovascular care.

To learn more about this report, Download Free Sample Report

The providers segment is expected to witness significant growth in the digital health for cardiovascular market, driven by increasing adoption of telecardiology, remote patient monitoring, AI-enabled diagnostics, electronic health records (EHRs), and clinical decision-support solutions across hospitals, cardiology centers, and clinics. Digital health technologies enable healthcare providers to remotely monitor patients with cardiovascular conditions, support early detection of abnormalities, improve care coordination, and facilitate personalized disease management. The integration of wearable and connected medical devices with digital platforms further enables continuous monitoring of parameters such as ECG, blood pressure, heart rate, and oxygen saturation, reducing the need for frequent in-person visits. In addition, growing emphasis on preventive and value-based care, reducing hospital readmissions, and improving clinical efficiency is expected to drive the adoption of digital cardiovascular health solutions among healthcare providers.

Regional Insights

North America dominated the digital health for cardiovascular market, accounting for the largest revenue share of 38.1% in 2025. Growth is driven by the high adoption of remote patient monitoring, wearable cardiac devices, AI-based diagnostics, and digital health platforms. Strong healthcare infrastructure, high healthcare IT spending, the rising burden of cardiovascular diseases, and increasing integration of digital tools with EHR systems further support market growth.

To learn more about this report, Download Free Sample Report

U.S. Digital Health For Cardiovascular Market Trends

The U.S. digital health for cardiovascular market dominated the North American market in 2025. Market growth is supported by the widespread adoption of remote patient monitoring, AI-enabled diagnostics, and digital cardiovascular imaging. For instance, in July 2025, EviCore updated its coverage guidelines to include Cleerly’s AI-based coronary plaque analysis, supporting broader adoption of AI-powered coronary imaging in the U.S. Increasing healthcare IT spending, advanced digital infrastructure, and the growing burden of cardiovascular diseases are further driving the adoption of digital health solutions for cardiovascular disease management.

Europe Digital Health For Cardiovascular Market Trends

The Europe digital health for cardiovascular market is driven by strong healthcare infrastructure, increasing adoption of remote patient monitoring, and growing use of AI-enabled cardiovascular diagnostics. The region is also benefiting from rising investments in digital health infrastructure and the integration of wearable devices, telehealth platforms, and electronic health records. In addition, the increasing burden of cardiovascular disease and the need for early diagnosis and continuous disease management are driving the adoption of digital cardiovascular solutions across hospitals and healthcare networks.

The UK digital health for cardiovascular market is driven by increasing adoption of digital health solutions across the NHS and private healthcare providers. Remote monitoring, AI-enabled diagnostics, and connected cardiac devices are increasingly being used to improve early detection and long-term cardiovascular disease management. For instance, in June 2026, Royal Devon University Healthcare NHS Foundation Trust was recognized for its digital care pathway, which provides 24/7 home heart monitoring for patients using wearable ECG devices. The system integrates wearable ECG data with the Trust’s electronic patient record, enabling continuous monitoring, faster diagnosis, and earlier clinical intervention. This End Use highlights the increasing integration of wearable cardiac monitoring with hospital information systems and is expected to support the growth of digital cardiovascular solutions in the UK.

The Germany digital health for cardiovascular market is supported by advanced healthcare infrastructure, increasing digitalization, and growing adoption of digital cardiovascular solutions. For instance, in September 2025, Germany added a new reimbursement code for the ProHerz digital health application, enabling physicians to bill for monitoring and evaluating patients with heart failure using the app. The application helps patients identify early changes in their condition and supports ongoing disease management. This development is strengthening the integration of prescription-based digital health applications into cardiovascular care and supporting market growth in Germany.

Asia Pacific Digital Health for Cardiovascular Market Insights

Asia Pacific is expected to register the fastest CAGR of 16.1% during the forecast period. Growth is driven by the rising burden of cardiovascular diseases, the increasing digitization of healthcare, and the growing adoption of remote monitoring, wearable devices, and AI-based cardiovascular diagnostics. Government investments in digital health infrastructure and the expansion of telehealth services are improving access to cardiac care, particularly in rural and underserved areas. For instance, in October 2025, China’s AI-enabled digital health ecosystem is increasingly being used for cardiovascular disease prevention, risk assessment, and remote monitoring.

The China digital health for cardiovascular market held a significant share of the Asia Pacific market in 2025. Market growth is supported by the rapid adoption of AI-based cardiovascular diagnostics and digital health platforms. For instance, in June 2025, Fudan University-affiliated Zhongshan Hospital and the Shanghai Institute for Advanced Research in Intelligent Science jointly launched CardioMind, an AI model specifically designed for cardiovascular care. The platform can analyze clinical information and multiple diagnostic data sources, including CT, echocardiography, and genetic testing, to support cardiovascular diagnosis and decision-making. This development highlights the increasing use of AI-enabled digital health solutions in China’s cardiovascular care system.

The India digital health for cardiovascular market  is expanding due to increasing healthcare digitization, rising demand for remote monitoring, and growing adoption of AI-enabled cardiovascular solutions. Government initiatives and investments in indigenous digital health technologies are improving access to preventive and cardiac care, particularly in underserved areas. For instance, in January 2026, India’s Technology Development Board supported the development of a continuous glucose monitoring device incorporating cardiovascular biomarkers to detect heart conditions early. The device is designed to enable continuous monitoring of health parameters and identify early signs of cardiovascular risk. Such initiatives are encouraging the development of locally produced connected health technologies and supporting the integration of digital monitoring into preventive cardiovascular care. This is expected to support the adoption of digital health solutions across hospitals, clinics, and home care settings in India.

Latin America Digital Health For Cardiovascular Market Insights

The Latin America digital health for cardiovascular market is witnessing increasing adoption of remote patient monitoring, telecardiology, wearable cardiac devices, and AI-enabled cardiovascular diagnostics. Market growth is supported by the rising burden of cardiovascular disease, expanding digital healthcare infrastructure, and growing demand for affordable, accessible cardiac care. For instance, in March 2026, Lenovo Brazil and the Heart Institute (InCor-HCFMUSP) presented TRAdA, an AI-enabled wearable solution for remote arrhythmia monitoring. The system continuously analyzes cardiac electrical signals and sends real-time alerts to healthcare professionals when abnormalities are detected. Such developments highlight the growing commercialization of AI-powered remote cardiac monitoring solutions and support the expansion of digital cardiovascular care across Latin America.

The Brazil digital health for cardiovascular market is growing owing to the rising burden of cardiovascular diseases, increasing adoption of telemedicine, and growing investments in digital healthcare infrastructure. Government initiatives promoting digital health and interoperability, along with greater integration of electronic health records, are further supporting market growth. As healthcare systems increasingly emphasize early disease detection, chronic disease management, and value-based care, the demand for digital cardiovascular solutions is expected to continue to grow across hospitals, specialty clinics, and home care settings.

Middle East & Africa Digital Health for Cardiovascular Market Insights

The Middle East & Africa digital health for cardiovascular market is growing due to increasing healthcare digitization, rising cardiovascular disease burden, and growing adoption of AI-enabled diagnostics and remote monitoring solutions. Governments and healthcare providers are investing in digital technologies to improve early diagnosis and continuous cardiac care. For instance, in August 2025, King Abdullah Medical City in Saudi Arabia launched a remote heart failure monitoring program to expand access to specialized cardiac care and support preventive intervention. The initiative demonstrates the increasing adoption of remote cardiovascular monitoring in the region and supports the expansion of digital health solutions for cardiovascular disease management.

The Saudi Arabia digital health for cardiovascular market is witnessing strong growth, supported by the country's Vision 2030 healthcare transformation strategy, increasing healthcare digitalization, and rising prevalence of cardiovascular diseases. In addition, initiatives by the Ministry of Health and the Saudi Health Information Exchange (NPHIES) are improving interoperability and enabling more integrated patient care. The growing adoption of remote patient monitoring, wearable cardiac devices, and AI-assisted clinical decision support is enhancing early diagnosis and long-term management of cardiovascular conditions.

Key Digital Health For Cardiovascular Company Insights

The players in the digital health for cardiovascular market are pursuing strategic initiatives, including partnerships, collaborations, acquisitions, and product launches, to expand their digital cardiovascular care capabilities, strengthen technological expertise, and broaden their market presence. Companies are increasingly focusing on AI-enabled diagnostics, remote patient monitoring, connected devices, digital therapeutics, and cardiovascular data analytics to improve patient outcomes and care delivery.

Key Digital Health For Cardiovascular Companies

The following key companies have been profiled for this study on the digital health for cardiovascular market

• Apple, Inc.

• Orange Business

• Epic Systems Corporation

• NXGN Management, LLC.

• Siemens Healthineers AG

• GE HealthCare

• CardiAI

• Cardiologs

• UltraSight

• HeartVista Inc. (Vista.ai)

• Viz.ai, Inc.

• RSIP Vision

• Cleerly, Inc.

Recent Developments:

• In July 2026, Karoo Health raised USD 16.2 million in Series A funding to expand its AI-native cardiovascular care platform. The company connects payers, providers, and patients through a unified workflow layer that supports earlier risk detection, better care coordination, and lower costs.

• In January 2026, CardioOne launched CardioOne Connect, an integrated digital platform combining ambulatory cardiac diagnostics, chronic care management, and remote patient monitoring. The platform connects with existing electronic medical records (EMRs) and provides care teams with continuous patient monitoring, coordinated care planning, and diagnostic insights through cloud-based technology.

• In March 2026, AISAP partnered with Cardiology Consultants of Philadelphia (CCP) to deploy an AI-enabled cardiac diagnostic platform. The collaboration will use AI-driven protocols across pilot sites and joint research initiatives to support the detection and management of heart failure and valvular disease. The partnership highlights the growing use of AI-based cardiovascular diagnostics within large cardiology networks .

• In October 2025, Bayosthiti AI, an Indian subsidiary of Biostate AI, partnered with Narayana Health to develop AI models specifically designed to predict cardiovascular disease in Indian populations. The collaboration involves a 12,000-patient study and aims to develop India-specific cardiac datasets and predictive models. This initiative is expected to support the development of more population-specific AI tools for cardiovascular risk assessment and early disease detection .

• In September 2025, The U.S. FDA cleared Apple’s smartwatch hypertension notification feature, which uses an AI algorithm and optical heart sensor data to flag patterns consistent with chronic high blood pressure.

• In March 2024, Wellysis, a Samsung subsidiary, collaborated with Artella Solutions (ARTELLA) to unveil its remote cardiac monitoring service in the U.S. This partnership is geared towards offering the FDA-cleared S-Patch electrocardiogram monitoring solution from ARTELLA across 10 states.

Global Digital Health For Cardiovascular Market Report Segmentation

This report forecasts revenue growth at the global, regional, & country levels and provides an analysis of industry trends in each sub segment from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global digital health for cardiovascular market on the basis of component, end-use and region:

To learn more about this report, Download Free Sample Report

• Component Outlook (Revenue, USD Million, 2021 - 2033)

  • Software

  • Hardware

  • Services

• End-use Outlook (Revenue, USD Million, 2021 - 2033)

  • Patients

  • Providers

  • Payers

  • Others

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • Australia

    • India

    • South Korea

    • Thailand

  • Central & South America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

Research Methodology

The digital health for cardiovascular market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing—reconciling supply-side and demand-side estimates—and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each digital health for cardiovascular segment quantified using the revenue-capture definitions in the table below.

Estimation Model - Model Details

The market was analyzed using a multi-dimensional research and estimation framework integrating cardiovascular disease burden assessment, digital health adoption modeling, connected device utilization analysis, software subscription modeling, healthcare IT expenditure assessment, company revenue mapping, reimbursement analysis, top-down market validation, and regional weighted-factor analysis.

Delivered Customizations

This report has been delivered with the following In-depth customizations